UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism

PloS one, 2020-04, Vol.15 (4), p.e0232354

2020

Volltextzugriff (PDF)

Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case‐cohort

Pharmacotherapy, 2024-06, Vol.44 (6), p.416-424

2024

Volltextzugriff (PDF)

The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment

PloS one, 2015-04, Vol.10 (4), p.e0122520-e0122520

2015

Volltextzugriff (PDF)

Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists

PloS one, 2016-12, Vol.11 (12), p.e0164485-e0164485

2016

Volltextzugriff (PDF)

Correction: Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism

PloS one, 2020-06, Vol.15 (6), p.e0234298-e0234298

2020

Volltextzugriff (PDF)

A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon

The New England journal of medicine, 2013-12, Vol.369 (24), p.2304-2312

2013

Volltextzugriff (PDF)

Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study

Journal of thrombosis and haemostasis, 2022-01, Vol.20 (1), p.92-103

2022

Volltextzugriff (PDF)

Association of VKORC1 polymorphisms and major bleedings in patients who are treated with vitamin K antagonists

Journal of internal medicine, 2023-01, Vol.293 (1), p.124-127

2023

Volltextzugriff (PDF)

Switching from vitamin K antagonists to direct oral anticoagulants in non‐valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?

Journal of thrombosis and haemostasis, 2022-02, Vol.20 (2), p.339-352

2022

Volltextzugriff (PDF)

Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial

British journal of haematology, 2020-09, Vol.190 (6), p.916-922

2020

Volltextzugriff (PDF)

Quality performance for indirect Xa inhibitor monitoring in patients using international external quality data

Clinical chemistry and laboratory medicine, 2020-11, Vol.58 (11), p.1921-1930

2020

Volltextzugriff (PDF)

Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns

Journal of thrombosis and haemostasis, 2020-06, Vol.18 (6), p.1390-1397

2020

Volltextzugriff (PDF)

Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy

British journal of haematology, 2010-05, Vol.149 (4), p.598-605

2010

Volltextzugriff (PDF)

Inhibitor incidence after intensive FVIII replacement for surgery in mild and moderate haemophilia A: a prospective national study in the Netherlands

British journal of haematology, 2012-06, Vol.157 (6), p.747-752

2012

Volltextzugriff (PDF)

Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

Pharmacoepidemiology and drug safety, 2021-08, Vol.30 (8), p.1027-1036

2021

Volltextzugriff (PDF)

Effect of multidose drug dispensing on the time in therapeutic range in patients using vitamin‐K antagonists: A randomized controlled trial

Journal of thrombosis and haemostasis, 2020-01, Vol.18 (1), p.70-78

2020

Volltextzugriff (PDF)

A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program

Thrombosis and haemostasis, 2009-03, Vol.101 (3), p.487-494

2009

Volltextzugriff (PDF)

Influence of haematocrit on international normalised ratio (INR) differences between a whole blood point-of-care coagulation monitor and reference prothrombin time in plasma

Thrombosis and haemostasis, 2008-12, Vol.100 (6), p.1181-1184

2008

Volltextzugriff (PDF)

The value of family history as a risk indicator for venous thrombosis

Archives of internal medicine (1960), 2009-03, Vol.169 (6), p.610

2009

Volltextzugriff (PDF)

Subtherapeutic oral anticoagulant therapy: frequency and risk factors

Thrombosis and haemostasis, 2009-03, Vol.101 (3), p.552-556

2009

Volltextzugriff (PDF)

Accuracy assessment of consecutive test strip lots for whole blood INR point-of-care instruments: clarifying the role of frozen plasma pools

Clinical chemistry and laboratory medicine, 2019-09, Vol.57 (9), p.1349-1357

2019

Volltextzugriff (PDF)

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

Research and practice in thrombosis and haemostasis, 2020-01, Vol.4 (1), p.141-153

2020

Volltextzugriff (PDF)

Quality Assessment of CoaguChek Point-of-Care Prothrombin Time Monitors: Comparison of the European Community-Approved Procedure and Conventional External Quality Assessment

Clinical chemistry (Baltimore, Md.), 2006-10, Vol.52 (10), p.1843-1847

2006

Volltextzugriff (PDF)

Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants

Research and practice in thrombosis and haemostasis, 2020-05, Vol.4 (4), p.586-593

2020

Volltextzugriff (PDF)

Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis

Research and practice in thrombosis and haemostasis, 2021-10, Vol.5 (7), p.e12597-n/a, Article e12597

2021

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(129)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(104)
Life Sciences & Biomedicine
(101)
Humans
(97)
Male
(62)
Female
(59)
Hematology
(58)
Biological And Medical Sciences
(54)
Medical Sciences
(53)
Middle Aged
(52)
Aged
(48)
Cardiovascular System & Cardiology
(43)
Peripheral Vascular Disease
(40)
Adult
(35)
International Normalized Ratio
(35)
Anticoagulants - Administration & Dosage
(30)
Aged, 80 And Over
(29)
Risk Factors
(26)
Anticoagulants
(25)
Anticoagulants - Therapeutic Use
(23)
Administration, Oral
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism

Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case‐cohort

The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment

Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists

Correction: Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism

A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon

Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study

Association of VKORC1 polymorphisms and major bleedings in patients who are treated with vitamin K antagonists

Switching from vitamin K antagonists to direct oral anticoagulants in non‐valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?

Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial

Quality performance for indirect Xa inhibitor monitoring in patients using international external quality data

Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns

Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy

Inhibitor incidence after intensive FVIII replacement for surgery in mild and moderate haemophilia A: a prospective national study in the Netherlands

Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

Effect of multidose drug dispensing on the time in therapeutic range in patients using vitamin‐K antagonists: A randomized controlled trial

A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program

Influence of haematocrit on international normalised ratio (INR) differences between a whole blood point-of-care coagulation monitor and reference prothrombin time in plasma

The value of family history as a risk indicator for venous thrombosis

Subtherapeutic oral anticoagulant therapy: frequency and risk factors

Accuracy assessment of consecutive test strip lots for whole blood INR point-of-care instruments: clarifying the role of frozen plasma pools

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

Quality Assessment of CoaguChek Point-of-Care Prothrombin Time Monitors: Comparison of the European Community-Approved Procedure and Conventional External Quality Assessment

Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants

Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis

Suchergebnisse filtern